BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1930560)

  • 1. Detection of antibody formation in mice, rats and rabbits immunized with different Pneumocystis carinii antigens.
    Roth A; Janitschke K
    Zentralbl Bakteriol; 1991 Apr; 275(1):123-32. PubMed ID: 1930560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with recombinant Pneumocystis carinii p55 antigen provides partial protection against infection: characterization of epitope recognition associated with immunization.
    Smulian AG; Sullivan DW; Theus SA
    Microbes Infect; 2000 Feb; 2(2):127-36. PubMed ID: 10742685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active immunization against Pneumocystis carinii with a recombinant P. carinii antigen.
    Wells J; Haidaris CG; Wright TW; Gigliotti F
    Infect Immun; 2006 Apr; 74(4):2446-8. PubMed ID: 16552076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoprotein A is the immunodominant antigen of Pneumocystis carinii in mice following immunization.
    Gigliotti F; McCool T
    Parasitol Res; 1996; 82(1):90-1. PubMed ID: 8825453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and characterization of monoclonal antibodies to human Pneumocystis carinii for the diagnosis of P. carinii pneumonia.
    Nato F; Contini C; Zamora-Zavala C; Viscardi P; Delia S; Mojon M; Mazie JC
    Eur J Med; 1992 Jun; 1(3):132-8. PubMed ID: 1341432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumocystis carinii antigen detection in rat serum and lung lavage.
    McNabb SJ; Graves DC; Kosanke SD; Moyer MJ; Ivey MH
    J Clin Microbiol; 1988 Sep; 26(9):1763-71. PubMed ID: 3263387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumocystis carinii host origin defines the antibody specificity and protective response induced by immunization.
    Gigliotti F; Harmsen AG
    J Infect Dis; 1997 Nov; 176(5):1322-6. PubMed ID: 9359734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of a monoclonal antibody with specificity for the pellicle of Pneumocystis carinii by hybridoma.
    Matsumoto Y; Amagai T; Yamada M; Imanishi J; Yoshida Y
    Parasitol Res; 1987; 73(3):228-33. PubMed ID: 2438684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with Pneumocystis Cross-Reactive Antigen 1 (Pca1) Protects Mice against Pneumocystis Pneumonia and Generates Antibody to Pneumocystis jirovecii.
    Tesini BL; Wright TW; Malone JE; Haidaris CG; Harber M; Sant AJ; Nayak JL; Gigliotti F
    Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28031260
    [No Abstract]   [Full Text] [Related]  

  • 10. Recognition of Pneumocystis carinii antigens by local antibody-secreting cells following resolution of P. carinii pneumonia in mice.
    Gigliotti F; Garvy BA; Haidaris CG; Harmsen AG
    J Infect Dis; 1998 Jul; 178(1):235-42. PubMed ID: 9652446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences exist in the immunoblotting profiles of cyst and trophozoite antigens of Pneumocystis carinii.
    Chatterton JM; Joss AW; Pennington TH; Ho-Yen DO
    J Med Microbiol; 1995 Feb; 42(2):120-6. PubMed ID: 7869347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of murine monoclonal antibodies to Pneumocystis carinii.
    Gigliotti F; Stokes DC; Cheatham AB; Davis DS; Hughes WT
    J Infect Dis; 1986 Aug; 154(2):315-22. PubMed ID: 3522758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum antibody responses to Pneumocystis carinii among different strains of normal and athymic mice.
    Walzer PD; Rutledge ME
    Infect Immun; 1982 Feb; 35(2):620-6. PubMed ID: 6976938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumocystis carinii organisms obtained from rats, ferrets, and mice are antigenically different.
    Bauer NL; Paulsrud JR; Bartlett MS; Smith JW; Wilde CE
    Infect Immun; 1993 Apr; 61(4):1315-9. PubMed ID: 8454333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation of antigenicity and serological reaction to Pneumocystis carinii in Korea.
    Park HY; Lee SU; Chae SW; Huh S; Yu JR; Kim J; Hong ST
    Korean J Parasitol; 1999 Jun; 37(2):109-15. PubMed ID: 10388269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary studies on the development of a vaccine for Pneumocystis carinii. I. Immunological and biochemical characterization.
    Pifer LL; Pifer DD; Woods DR; Joyner RE; Edwards CC
    Vaccine; 1986 Dec; 4(4):257-65. PubMed ID: 3541429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of rat-derived antigen in the serodiagnosis of Pneumocystis carinii infection.
    Chatterton JMW; Joss AWL; Pennington TH; Ho-Yen DO
    J Med Microbiol; 1999 Jul; 48(7):681-687. PubMed ID: 10403419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant antibody and cellular responses to Pneumocystis major surface glycoprotein variants in mice.
    Bishop LR; Helman D; Kovacs JA
    BMC Immunol; 2012 Jul; 13():39. PubMed ID: 22788748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zymolyase treatment exposes p55 antigen of Pneumocystis carinii.
    Broomall KR; Morris RE; Walzer PD; Smulian AG
    J Eukaryot Microbiol; 1998; 45(3):284-9. PubMed ID: 9627988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic comparisons of Pneumocystis carinii strains obtained from rats, ferrets, and mice using convalescent sera from the same sources.
    Bauer NL; Paulsrud JR; Bartlett MS; Smith JW; Wilde CE
    J Protozool; 1991; 38(6):166S-168S. PubMed ID: 1818152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.